FDA Investigator Jasmine N Thompson
Jasmine N Thompson has conducted inspections on 7 sites in 1 countries as of 29 May 2002. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
29 May 2002
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jasmine N Thompson:
Aileen Santos,
Alan P Kurtzberg,
Amir Alavi,
Angelina M Albert,
Arie C Menachem,
Arsen Karapetyan,
Babajide Michael Osunsanmi,
Bichsa T Tran,
Binh T Nguyen,
Brian P Putz,
Brian Ravitch,
Carla J Lundi,
Carla M Fernandez Borges,
Caryn M Mcnab,
Cassandra L Abellard,
Chorng M Cheng,
Christopher R Czajka,
Daniel J Roberts,
Darren S Brown,
David H Hsu,
Debra J Fracassa,
Diane Cvan Leeuwen,
Diane R Weidley,
Elaine A Bunch,
Esther B Gamallo Herrera,
Finn A Slizza,
Gene D Arcy,
Geraldine M Peregrin,
Jacob W Reynolds,
Jamie M Du,
Jane S Wernberg,
Jennifer M Gogley,
Jocelyn E Massey,
Joey V Quitania,
John A Gonzalez,
Joshua P Wireman,
Katherine E Jacobitz,
Kham Phommachanh,
LCDR Wilfred A Darang,
Lilly O Barton,
Liming Zhang,
Linda Thai,
M Jasnethoson Thompson,
Marcus F Yambot,
Mark A Tucker,
Mark C Saale,
Maxyne T Lam,
Mei Chi Siu,
Michael A Charles,
Michael S Araneta,
Mihaly S Ligmond,
Minh D Phan,
Nancy E Byerly,
Naveen B Walker,
Richmond K Yip,
Robert T Lorenz,
Santiago Gallardo Johnson,
Sonia R Peterson,
Sonya L Karsik, RAC,
Sue Lee Chan,
Sumit Sen,
Tamala P Magee,
Terri L Dodds,
Thao T Kwan,
Tracey T Duong,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Vasant G Malshet, PhD,
Virgilio F Pacio, CSO,
Walden H Lee,
Yumi J Hiramine,
Yvette E Guillermo
Jasmine N Thompson's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2001 | FDA 483 | Weber Laboratories Inc - Form 483, 2001-05-17 |
June, 2002 | FDA 483 | KC Pharmaceuticals, Inc. - Form 483, 2002-06-19 |
May, 2001 | EIR | Weber Laboratories Inc - EIR, 2001-05-17 |
February, 2002 | FDA 483 | North American Science Associates, LLC - Form 483, 2002-02-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more